Covaxin Patent Issue: Bharat Biotech to Credit ICMR

Bharat Biotech Rectifies Patent Mistake, Includes ICMR Scientists

Hyderabad-based Bharat Biotech International Limited (BBIL), known for manufacturing Covaxin, India’s first indigenous Covid-19 vaccine, admitted to making an “inadvertent mistake” by not listing scientists from the Indian Council of Medical Research (ICMR) as ‘co-inventors’ in patent applications filed in India and abroad. The company has promised to rectify this and include their names in new patent filings.